1.Establishment of Patient-Derived Xenograft (PDX) Zebrafish Model of Multiple Myeloma and Its Application in Drug Screening.
Zhen YU ; Ying LI ; Ke-Fei WANG ; Lu WANG ; Mu HAO
Journal of Experimental Hematology 2023;31(6):1745-1749
		                        		
		                        			OBJECTIVE:
		                        			To establish a MM patient-derived tumor xenograft model (MM-PDX) in zebrafish, and to evaluate the anti-myeloma activity of indirubin-3'-monoxime(I3MO) using this model.
		                        		
		                        			METHODS:
		                        			Zebrafish embryos 2 days after fertilization were transplanted with fluorescence labeled myeloma primary tumor cells, the survival of primary tumor cells in zebrafish was observed at 0,16 and 24 hours after cell injection. The zebrafish embryos after tumor cell transplantation were randomly divided into control group, BTZ treatment and I3MO treatment group. Before and 24 hours after treatment with BTZ and I3MO, the positive area with calcein or Dil in zebrafish were observed under fluorescence microscope to reflect the survival of tumor cells, and it was verified.
		                        		
		                        			RESULTS:
		                        			MM patient derived tumor cells survived in zebrafish. The construction of MM-PDX was successful. Compared with control group, the fluo- rescence area of the BTZ and I3MO treatment groups in zebrafish were significantly decreased(P<0.05), and BTZ and I3MO significantly inhibited the survival of MM cells in zebrafish.
		                        		
		                        			CONCLUSION
		                        			MM-PDX model was successfully established. Zebrafish model derived from tumor cells of MM patients can be used as a tool for drug screening of MM.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Bortezomib/therapeutic use*
		                        			;
		                        		
		                        			Cell Line, Tumor
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Heterografts
		                        			;
		                        		
		                        			Multiple Myeloma/pathology*
		                        			;
		                        		
		                        			Xenograft Model Antitumor Assays
		                        			;
		                        		
		                        			Zebrafish
		                        			
		                        		
		                        	
2.Advances of using microfluidic chips for research and diagnosis of pulmonary inflammatory diseases.
Taoran XIA ; Wei ZOU ; Jing LIU
Chinese Journal of Biotechnology 2021;37(11):3905-3914
		                        		
		                        			
		                        			Microfluidic chip technology integrates the sample preparation, reaction, separation and detection on a chip. It consists a network of microchannels, which controls the whole system through fluid. With the advantages of portability, high throughput, and the ability to simulate the microenvironment in vivo, it has a broad application prospect in the research of disease diagnosis, pathogenesis and drug screening. Pulmonary inflammatory disease is a common disease usually caused by bacterial, viral and fungal infections. Early pneumonia is often difficult to diagnose due to lack of obvious respiratory symptoms or the symptoms are mostly atypical, but the disease progresses rapidly. Recently, microfluidic chip technology has been increasingly used to the study of pulmonary inflammatory diseases. In particular, it has been used to develop a "lung-on-a-chip" model, which can reproduce the key structure, function and mechanical properties of human alveolar capillary interface (i.e., the basic functional unit of a living lung), and well simulate the alveoli in vitro. Compared with the cell and animal models, this multifunctional micro experimental platform has great advantages. This article summarizes the advances of using microfluidic chips for the research and diagnosis of pulmonary inflammatory diseases, with the aim to provide new ideas for researchers in this area.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lung
		                        			;
		                        		
		                        			Microfluidic Analytical Techniques
		                        			;
		                        		
		                        			Microfluidics
		                        			
		                        		
		                        	
3.High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
Yao ZHAO ; Xiaoyu DU ; Yinkai DUAN ; Xiaoyan PAN ; Yifang SUN ; Tian YOU ; Lin HAN ; Zhenming JIN ; Weijuan SHANG ; Jing YU ; Hangtian GUO ; Qianying LIU ; Yan WU ; Chao PENG ; Jun WANG ; Chenghao ZHU ; Xiuna YANG ; Kailin YANG ; Ying LEI ; Luke W GUDDAT ; Wenqing XU ; Gengfu XIAO ; Lei SUN ; Leike ZHANG ; Zihe RAO ; Haitao YANG
Protein & Cell 2021;12(11):877-888
		                        		
		                        			
		                        			A new coronavirus (SARS-CoV-2) has been identified as the etiologic agent for the COVID-19 outbreak. Currently, effective treatment options remain very limited for this disease; therefore, there is an urgent need to identify new anti-COVID-19 agents. In this study, we screened over 6,000 compounds that included approved drugs, drug candidates in clinical trials, and pharmacologically active compounds to identify leads that target the SARS-CoV-2 papain-like protease (PLpro). Together with main protease (M
		                        		
		                        		
		                        		
		                        			Antiviral Agents/therapeutic use*
		                        			;
		                        		
		                        			Binding Sites
		                        			;
		                        		
		                        			COVID-19/virology*
		                        			;
		                        		
		                        			Coronavirus Papain-Like Proteases/metabolism*
		                        			;
		                        		
		                        			Crystallography, X-Ray
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Drug Repositioning
		                        			;
		                        		
		                        			High-Throughput Screening Assays/methods*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Imidazoles/therapeutic use*
		                        			;
		                        		
		                        			Inhibitory Concentration 50
		                        			;
		                        		
		                        			Molecular Dynamics Simulation
		                        			;
		                        		
		                        			Mutagenesis, Site-Directed
		                        			;
		                        		
		                        			Naphthoquinones/therapeutic use*
		                        			;
		                        		
		                        			Protease Inhibitors/therapeutic use*
		                        			;
		                        		
		                        			Protein Structure, Tertiary
		                        			;
		                        		
		                        			Recombinant Proteins/isolation & purification*
		                        			;
		                        		
		                        			SARS-CoV-2/isolation & purification*
		                        			
		                        		
		                        	
4.Study on liver diseases with zebrafish as an important tool.
Zhi-Qi LI ; Yue XU ; Xia ZHAO ; Zhe JIA ; Zhao-Yi WANG ; Dan FENG ; Cui-Bai LI ; Zhi-Qiang MA ; Chong-Jun ZHAO ; Rui-Chao LIN
China Journal of Chinese Materia Medica 2021;46(2):320-332
		                        		
		                        			
		                        			With the increasing incidence of hepatobiliary diseases, it is particularly important to understand the role of molecular, cellular and physiological factors in the clinical diagnosis and treatment with traditional Chinese medicine(TCM) in the development of liver disease. Appropriate animal models can help us identify the possible mechanisms of relevant diseases. Danio rerio(zebrafish) model was traditionally used to study embryonic development, and has been gradually used in screening and evaluation of liver diseases and relevant drug in recent years. Zebrafish embryos develop rapidly and the digestive organs of 5-day-old juvenile fish are all mature. At this stage, they may develop hepatobiliary diseases induced by developmental defects or compounds. Zebrafish liver is similar to human liver in cell composition, function, signal transduction, response to injury and cell process mediating liver disease. Furthermore, due to the high conservation of genes and proteins between humans and zebrafish, zebrafish becomes an alternative system for studying basic mechanisms of liver disease. Therefore, genetic screening could be performed to identify new genes involving specific disease processes, and chemical screening could be made for drugs in specific processes. This paper briefly introduced the experimental properties of zebrafish as model system, emphasized the study progress of zebrafish models for pathological mechanism of liver diseases, especially fatty liver, and drug screening and evaluation, so as to provide ideas and techniques for the future liver toxicity assessment of TCM.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Liver Diseases/genetics*
		                        			;
		                        		
		                        			Medicine, Chinese Traditional
		                        			;
		                        		
		                        			Zebrafish/genetics*
		                        			
		                        		
		                        	
5.Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Rui XIONG ; Leike ZHANG ; Shiliang LI ; Yuan SUN ; Minyi DING ; Yong WANG ; Yongliang ZHAO ; Yan WU ; Weijuan SHANG ; Xiaming JIANG ; Jiwei SHAN ; Zihao SHEN ; Yi TONG ; Liuxin XU ; Yu CHEN ; Yingle LIU ; Gang ZOU ; Dimitri LAVILLETE ; Zhenjiang ZHAO ; Rui WANG ; Lili ZHU ; Gengfu XIAO ; Ke LAN ; Honglin LI ; Ke XU
Protein & Cell 2020;11(10):723-739
		                        		
		                        			
		                        			Emerging and re-emerging RNA viruses occasionally cause epidemics and pandemics worldwide, such as the on-going outbreak of the novel coronavirus SARS-CoV-2. Herein, we identified two potent inhibitors of human DHODH, S312 and S416, with favorable drug-likeness and pharmacokinetic profiles, which all showed broad-spectrum antiviral effects against various RNA viruses, including influenza A virus, Zika virus, Ebola virus, and particularly against SARS-CoV-2. Notably, S416 is reported to be the most potent inhibitor so far with an EC of 17 nmol/L and an SI value of 10,505.88 in infected cells. Our results are the first to validate that DHODH is an attractive host target through high antiviral efficacy in vivo and low virus replication in DHODH knock-out cells. This work demonstrates that both S312/S416 and old drugs (Leflunomide/Teriflunomide) with dual actions of antiviral and immuno-regulation may have clinical potentials to cure SARS-CoV-2 or other RNA viruses circulating worldwide, no matter such viruses are mutated or not.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antiviral Agents
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Betacoronavirus
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Binding Sites
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Cell Line
		                        			;
		                        		
		                        			Coronavirus Infections
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Crotonates
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Cytokine Release Syndrome
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Gene Knockout Techniques
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Influenza A virus
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Leflunomide
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred BALB C
		                        			;
		                        		
		                        			Orthomyxoviridae Infections
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Oseltamivir
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Oxidoreductases
		                        			;
		                        		
		                        			antagonists & inhibitors
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Pandemics
		                        			;
		                        		
		                        			Pneumonia, Viral
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Protein Binding
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Pyrimidines
		                        			;
		                        		
		                        			biosynthesis
		                        			;
		                        		
		                        			RNA Viruses
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Structure-Activity Relationship
		                        			;
		                        		
		                        			Toluidines
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Ubiquinone
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Virus Replication
		                        			;
		                        		
		                        			drug effects
		                        			
		                        		
		                        	
6.Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase.
Protein & Cell 2020;11(10):699-702
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Betacoronavirus
		                        			;
		                        		
		                        			Coronavirus Infections
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Drug Discovery
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Enzyme Inhibitors
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Molecular Structure
		                        			;
		                        		
		                        			Orthomyxoviridae Infections
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Oseltamivir
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Oxidoreductases
		                        			;
		                        		
		                        			antagonists & inhibitors
		                        			;
		                        		
		                        			Pandemics
		                        			;
		                        		
		                        			Pneumonia, Viral
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Pyrimidines
		                        			;
		                        		
		                        			biosynthesis
		                        			
		                        		
		                        	
7.Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP.
Jing MA ; Xiao-Qian HUO ; Xi CHEN ; Wei-Xing ZHU ; Mei-Cun YAO ; Yan-Jiang QIAO ; Yan-Ling ZHANG
China Journal of Chinese Materia Medica 2020;45(6):1219-1224
		                        		
		                        			
		                        			With the rapid outbreak of COVID-19, traditional Chinese medicine(TCM) has been playing an active role against the epidemic. However, the screening of TCM is limited by the development cycle and laboratory conditions, which greatly limits the screening speed. This study established optimization docking models and virtual screening to discovery potential active herbs for the prevention and treatment of the novel coronavirus based on molecular docking technology. The crystal structures of 3 CL protease(Mpro) and papain-like protease(PLP) were obtained from PDB database and homologous modeling respectively, and were used to conduct virtual screening of TCMD 2009 database by CDOCKER program. The ingredients scored in the top 100 were selected respectively, and the candidate herbs were ranked by the numbers of hit molecules. Based on Mpro inhibitors screening, 12 322 potential active components were obtained, and the representative active components included aster pentapeptide A, ligustrazine, salvianolic acid B, etc., and Zingiberis Rhizoma Recens, Asteris Radix et Rhizoma, Notoginseng Radix et Rhizoma, Chuanxiong Rhizoma, Salviae Miltiorrhizae Radix et Rhizoma, Zingiberis Rhizoma, Dianthi Herba, Rhei Radix et Rhizoma, Cistanches Herba were obtained. While 11 294 potential active ingredients were obtained by PLP inhibitor screening, representative active ingredients included gingerketophenol, ginkgol alcohol, ferulic acid, etc., and Codonopsis Radix, Notopterygii Rhizoma et Radix, Zingiberis Rhizoma Recens, Ginkgo Semen, Chuanxiong Rhizoma, Trichosanthis Fructus, Paeoniae Radix Alba, Psoraleae Fructus, Sophorae Flavescentis Radix, Notoginseng Radix et Rhizoma, Angelicae Sinensis Radix were chosen. By combining the diagnosis and treatment scheme of Hunan province's and angiotensin converting enzyme 2(ACE2) inhibitors screening from literature, present study also discussed the rational application of candidate herbs to this epidemic situation. Trichosanthis Fructus obtained by PLP inhibitors screening and Fritillaria verticillata obtained by ACE2 inhibitors screening were parts of the Sangbei Zhisou Powder and Xiaoxianxiong Decoction, which might be applicable to the syndromes of cough and dyspnea. Rhei Radix et Rhizoma screened by Mpro and Trichosanthis Fructus screened by PLP were contained in Maxing Shigan Decoction and Xuanbai Chengqi Decoction, and could be applied to the syndromes of epidemic virus blocking lung. Mori Folium, Lonicerae Japonicae Flos and Forsythiae Fructus obtained by ACE2 inhibitors screening were included in the Sangju Decoction and Yinqiaosan, which might be applicable to the syndromes of warm pathogen attacking lung and cough and dyspnea. The results of this study are intended to provide a reference for the further development of traditional Chinese medicine to deal with the new epidemic.
		                        		
		                        		
		                        		
		                        			Angiotensin-Converting Enzyme 2
		                        			;
		                        		
		                        			Angiotensin-Converting Enzyme Inhibitors/pharmacology*
		                        			;
		                        		
		                        			Betacoronavirus/drug effects*
		                        			;
		                        		
		                        			COVID-19
		                        			;
		                        		
		                        			Coronavirus Infections/drug therapy*
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Drugs, Chinese Herbal/pharmacology*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Medicine, Chinese Traditional
		                        			;
		                        		
		                        			Molecular Docking Simulation
		                        			;
		                        		
		                        			Pandemics
		                        			;
		                        		
		                        			Peptidyl-Dipeptidase A
		                        			;
		                        		
		                        			Pneumonia, Viral/drug therapy*
		                        			;
		                        		
		                        			SARS-CoV-2
		                        			;
		                        		
		                        			COVID-19 Drug Treatment
		                        			
		                        		
		                        	
8.Machine-Learning Based Automatic and Real-time Detection of Mouse Scratching Behaviors
Ingyu PARK ; Kyeongho LEE ; Kausik BISHAYEE ; Hong Jin JEON ; Hyosang LEE ; Unjoo LEE
Experimental Neurobiology 2019;28(1):54-61
		                        		
		                        			
		                        			Scratching is a main behavioral response accompanied by acute and chronic itch conditions, and has been quantified as an objective correlate to assess itch in studies using laboratory animals. Scratching has been counted mostly by human annotators, which is a time-consuming and laborious process. It has been attempted to develop automated scoring methods using various strategies, but they often require specialized equipment, costly software, or implantation of device which may disturb animal behaviors. To complement limitations of those methods, we have adapted machine learning-based strategy to develop a novel automated and real-time method detecting mouse scratching from experimental movies captured using monochrome cameras such as a webcam. Scratching is identified by characteristic changes in pixels, body position, and body size by frame as well as the size of body. To build a training model, a novel two-step J48 decision tree-inducing algorithm along with a C4.5 post-pruning algorithm was applied to three 30-min video recordings in which a mouse exhibits scratching following an intradermal injection of a pruritogen, and the resultant frames were then used for the next round of training. The trained method exhibited, on average, a sensitivity and specificity of 95.19% and 92.96%, respectively, in a performance test with five new recordings. This result suggests that it can be used as a non-invasive, automated and objective tool to measure mouse scratching from video recordings captured in general experimental settings, permitting rapid and accurate analysis of scratching for preclinical studies and high throughput drug screening.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Animals, Laboratory
		                        			;
		                        		
		                        			Behavior, Animal
		                        			;
		                        		
		                        			Body Size
		                        			;
		                        		
		                        			Complement System Proteins
		                        			;
		                        		
		                        			Decision Trees
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Injections, Intradermal
		                        			;
		                        		
		                        			Machine Learning
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Motion Pictures as Topic
		                        			;
		                        		
		                        			Pruritus
		                        			;
		                        		
		                        			Research Design
		                        			;
		                        		
		                        			Sensitivity and Specificity
		                        			;
		                        		
		                        			Video Recording
		                        			
		                        		
		                        	
9.Effects of Carpobrotus edulis Extract on Oxidative Stress and 158N Oligodendrocyte Death.
Amira ZARROUK ; Mohammed Ali SMACH ; Jawhar HAFSA ; Randa SGHAIER ; Hatem MAJDOUB ; Mohammed HAMMAMI ; Bassem CHARFEDDINE
Biomedical and Environmental Sciences 2019;32(4):291-299
		                        		
		                        			OBJECTIVE:
		                        			Age-related diseases, including neurodegenerative diseases, are associated with oxidative stress and lipid peroxidation, and increase the levels of cholesterol auto-oxidation products such as 7β-hydroxycholesterol (7β-OHC). Thus, it is imperative to identify agents that can prevent 7β-OHC-induced side-effects.
		                        		
		                        			METHODS:
		                        			We evaluated the potential protective effects of Carpobrotus edulis ethanol-water extract (EWe) on murine oligodendrocytes (158N) cultured in the absence or presence of 7β-OHC (20 μg/mL, 24 h). The cells were incubated with EWe (20-200 µg/mL) 2 h before 7β-OHC treatment. Mitochondrial activity and cell growth were evaluated with the MTT assay. Photometric methods were used to analyze antioxidant enzyme [catalase (CAT) and glutathione peroxidase (GPx)] activities and the generation of lipid and protein oxidation products [malondialdehyde (MDA), conjugated diene (CD), and carbonylated proteins (CPs)].
		                        		
		                        			RESULTS:
		                        			Treatment with 7β-OHC induced cell death and oxidative stress (reflected by alteration in CAT and SOD activities). Overproduction of lipid peroxidation products (MDA and CDs) and CPs was also reported. The cytotoxic effects associated with 7β-OHC were attenuated by 160 μg/mL of EWe of C. edulis. Cell death induced by 7β-OHC treatment was ameliorated, GPx and CAT activities were restored to normal, and MDA, CD, and CP levels were reduced following C. edulis extract treatment.
		                        		
		                        			CONCLUSION
		                        			These data demonstrate the protective activities of C. edulis EWe against 7β-OHC-induced disequilibrium in the redox status of 158N cells, indicative of the potential role of this plant extract in the prevention of neurodegenerative diseases.
		                        		
		                        		
		                        		
		                        			Aizoaceae
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Cell Line
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Hydroxycholesterols
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Neurodegenerative Diseases
		                        			;
		                        		
		                        			prevention & control
		                        			;
		                        		
		                        			Neuroprotection
		                        			;
		                        		
		                        			Oligodendroglia
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Oxidative Stress
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Phytotherapy
		                        			;
		                        		
		                        			Plant Extracts
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			therapeutic use
		                        			
		                        		
		                        	
10.NANOG Alleviates the Damage of Human Hair Follicle Mesenchymal Stem Cells Caused by H2O2 through Activation of AKT Pathway.
Jia Hong SHI ; Kui Yang ZUO ; Ying Yao ZHANG ; Bo WANG ; Xing HAN ; Ao Bo LIAN ; Jin Yu LIU
Biomedical and Environmental Sciences 2019;32(4):272-280
		                        		
		                        			OBJECTIVE:
		                        			To explore the protective effect of NANOG against hydrogen peroxide (H2O2) -induced cell damage in the human hair follicle mesenchymal stem cells (hHF-MSCs).
		                        		
		                        			METHODS:
		                        			NANOG was expressed from a lentiviral vector, pLVX-IRES-ZsGreen. NANOG hHF-MSCs and vector hHF-MSCs were treated with 400 μmol/L hydrogen peroxide (H2O2) for 2 h, the cell survival rate, cell morphology, ROS production, apoptosis and expression of AKT, ERK, and p21 were determined and compared.
		                        		
		                        			RESULTS:
		                        			Our results showed that NANOG could activate AKT and upregulate the expression of p-AKT, but not p-ERK. When treated with 400 μmol/L H2O2, NANOG hHF-MSCs showed higher cell survival rate, lower ROS production and apoptosis, higher expression of p-AKT, higher ratio of p-AKT/AKT.
		                        		
		                        			CONCLUSION
		                        			Our results suggest that NANOG could protect hHF-MSCs against cell damage caused by H2O2 through activating AKT signaling pathway.
		                        		
		                        		
		                        		
		                        			Cell Survival
		                        			;
		                        		
		                        			Drug Evaluation, Preclinical
		                        			;
		                        		
		                        			Hair Follicle
		                        			;
		                        		
		                        			cytology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hydrogen Peroxide
		                        			;
		                        		
		                        			Lentivirus
		                        			;
		                        		
		                        			Mesenchymal Stem Cells
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Nanog Homeobox Protein
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Oxidative Stress
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Phosphatidylinositol 3-Kinases
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Proto-Oncogene Proteins c-akt
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Signal Transduction
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail